ONCO-DART Trademark

Trademark Overview


On Thursday, September 19, 2013, a trademark application was filed for ONCO-DART with the United States Patent and Trademark Office. The USPTO has given the ONCO-DART trademark a serial number of 86069056. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 10, 2019. This trademark is owned by MacroGenics, Inc.. The ONCO-DART trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Production and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases

Discovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
onco-dart

General Information


Serial Number86069056
Word MarkONCO-DART
Filing DateThursday, September 19, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, May 10, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProduction and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
Goods and ServicesDiscovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 26, 2013
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 26, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMacroGenics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Monday, May 13, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, May 10, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, September 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 28, 2018NON-FINAL ACTION E-MAILED
Friday, September 28, 2018NON-FINAL ACTION WRITTEN
Saturday, September 8, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Saturday, September 8, 2018ASSIGNED TO LIE
Tuesday, February 20, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 7, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 6, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 4, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 4, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 4, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 3, 2015ASSIGNED TO LIE
Tuesday, January 27, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 18, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 18, 2014LETTER OF SUSPENSION E-MAILED
Friday, July 18, 2014SUSPENSION LETTER WRITTEN
Friday, June 27, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 26, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 26, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 31, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 31, 2013NON-FINAL ACTION E-MAILED
Tuesday, December 31, 2013NON-FINAL ACTION WRITTEN
Monday, December 30, 2013ASSIGNED TO EXAMINER
Thursday, September 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 23, 2013NEW APPLICATION ENTERED IN TRAM